Time from orphan drug design to final exclusivity 2018, by current status
This statistic depicts the average number of years from orphan drug designation to last remaining exclusivity as of November 2018, by current exclusivity status. According to the data, drugs that were facing generic/biosimilar competition had an average of 12 years from designation to last remaining exclusivity.